Who
William J. Febbo
Director
Company insider
Files Form 4 as: Director, Myomo; CEO, OptimizeRx; Director, Augmedix; Director, Modular Medical; Director and Other, LifeMD; Director, Merriman Holdings.
In numbers
- Trades disclosed
- 112
- Buys
- 14
- Sells
- 9
- Bought
- $555K
- Sold
- $12.0M
- Companies
- 6
- Companies where not an officer
- 5
- First trade
- 26 Nov 2007
- Last trade
- 25 Jun 2026
- Last filed
- 26 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 25 Jun 2026filed 26 Jun 2026 | MYO MyomoMedical Devices | SEC FORM 4 Code A | —78,704 at $0.00 | filing |
| 25 Jun 2026filed 26 Jun 2026 | MYO MyomoMedical Devices | SEC FORM 4 Code A | —78,704 at $0.00 | filing |
| 14 Apr 2026filed 16 Apr 2026 | MYO MyomoMedical Devices | SEC FORM 4 Code A | —45,000 at $0.00 | filing |
| 14 Apr 2026filed 16 Apr 2026 | MYO MyomoMedical Devices | SEC FORM 4 Code A | —45,000 at $0.00 | filing |
| 14 Feb 2025filed 20 Feb 2025 | OPRX OptimizeRxBusiness Services | SEC FORM 4 Code F | $2,663401 at $6.64 | filing |
| 12 Dec 2024filed 16 Dec 2024 | OPRX OptimizeRxBusiness Services | SEC FORM 4 Bought | $100K20,000 at $5.01 | filing |
| 2 Oct 2024filed 4 Oct 2024 | Augmedixoption or derivative | SEC FORM 4 Code D | —50,000 at $0.00 | filing |
| 2 Oct 2024filed 4 Oct 2024 | Augmedix | SEC FORM 4 Code D | $382K162,583 at $2.35 | filing |
| 13 Jul 2024filed 15 Jul 2024 | Augmedixoption or derivative | SEC FORM 4 Code M | —21,598 at $0.00 | filing |
| 13 Jul 2024filed 15 Jul 2024 | Augmedix | SEC FORM 4 Code M | —21,598 | filing |
| 18 Apr 2024filed 12 Jun 2024 | OPRX OptimizeRxoption or derivative · Business Services | SEC FORM 4 Code M | —28,895 at $0.00 | filing |
| 18 Apr 2024filed 12 Jun 2024 | OPRX OptimizeRxBusiness Services | SEC FORM 4 Code M | —28,895 at $0.00 | filing |
| 18 Apr 2024filed 12 Jun 2024 | OPRX OptimizeRxBusiness Services | SEC FORM 4 Code F | $7,312782 at $9.35 | filing |
| 15 Apr 2024filed 17 Apr 2024 | OPRX OptimizeRxBusiness Services | SEC FORM 4 Code A | —60,000 at $0.00 | filing |
| 15 Feb 2024filed 24 Apr 2024 | OPRX OptimizeRxBusiness Services | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 9 Jan 2024filed 18 Jan 2024 | OPRX OptimizeRxoption or derivative · Business Services | SEC FORM 4 Code M | —9,628 at $0.00 | filing |
| 9 Jan 2024filed 18 Jan 2024 | OPRX OptimizeRxBusiness Services | SEC FORM 4 Code M | —9,628 at $0.00 | filing |
| 9 Jan 2024filed 18 Jan 2024 | OPRX OptimizeRxBusiness Services | SEC FORM 4 Code F | $38K2,884 at $13.25 | filing |
| 13 Jul 2023filed 17 Jul 2023 | Augmedixoption or derivative | SEC FORM 4 Code A | —21,598 at $0.00 | filing |
| 30 Jun 2023filed 5 Jul 2023 | MODD Modular MedicalMedical Devices | SEC FORM 4 Code A | —2,500 | filing |
News
No headline names them, or the companies they trade most, lately.